DJIA 17,820.11 100.19 0.57%
NASDAQ 5,134.18 25.52 0.50%
S&P 500 2,093.89 13.48 0.65%
market minute promo

GlaxoSmithKline (NYSE: GSK)

company name or ticker
Company Photos
(Click to zoom)

Would an Ebola Vaccine Move Regeneron Pharmaceuticals' Bottom Line?

Regeneron Pharmaceuticals has won a BARDA agreement to develop a potential vaccine for the Ebola virus. How big of a deal is it for Regeneron investors today?

Gilead's Letairis Gets FDA Nod in Combination with Adcirca

3 Drugs Stocks Moving The Industry Upward

Mirna Therapeutics: A Healthy IPO To Start The Week

Clinton Proposals Could Spell Trouble for These 3 Drugmakers

An empowered Medicare program could pressure sales for GlaxoSmithKline, Merck, and Celgene.

3 Stocks We're Ready to Sell

When the market gets choppy, it can be a good time take a hard look at your portfolio.

Glaxo's Eosinophilic Asthma Drug Nucala Wins CHMP Backing

GlaxoSmithKline (GSK) Stock: Is the Worst Over?

3 Drugs Stocks Pushing Industry Growth

Buy-Rated Dividend Stocks In The Top 3: GSK, WY, LVS